This Article Full Text Full Text (PDF) All Versions of this Article: 107/2/245    most recent 01.CIR.0000044387.23578.E9v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Beattie, M. S. Articles by Whooley, M. A. Search for Related Content PubMed PubMed Citation Articles by Beattie, M. S. Articles by Whooley, M. A. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Statins Related Collections Pathophysiology Chronic ischemic heart disease

(Circulation. 2003;107:245.)
© 2003 American Heart Association, Inc.

Clinical Investigation and Reports

C-Reactive Protein and Ischemia in Users and Nonusers of ß-Blockers and Statins

Data From the Heart and Soul Study

Mary S. Beattie, MD; Michael G. Shlipak, MD, MPH; Haiying Liu, MD, MPH; Warren S. Browner, MD, MPH; Nelson B. Schiller, MD; Mary A. Whooley, MD

From the Departments of Medicine (M.S.B., M.G.S., W.S.B., N.B.S., M.A.W.) and Epidemiology and Biostatistics (M.G.S., W.S.B., M.A.W.) and the Division of Cardiology (N.B.S.), University of California, San Francisco; the Section of General Internal Medicine, VA Medical Center (M.G.S., H.L., M.A.W.); and Research Institute, California Pacific Medical Center (W.S.B.), San Francisco.

Correspondence to M.A. Whooley, MD, VA Medical Center (111A1), 4150 Clement St, San Francisco, CA 94121. E-mail whooley{at}itsa.ucsf.edu

Background— Elevated levels of C-reactive protein (CRP) are associated with an increased risk of coronary events, but whether inflammation is associated with inducible ischemia in patients with stable coronary disease is unknown.

Methods and Results— We recruited patients with known coronary disease from 2 VA Medical Centers and 1 University-based medical center for the Heart and Soul Study. We measured CRP levels in 118 participants who had exercise-induced ischemia and in 111 who did not have inducible ischemia, as determined by stress echocardiography. We used logistic regression to examine the risk of exercise-induced ischemia associated with elevated CRP. We found that 75% (39/52) of participants in the highest CRP category (>0.38 mg/dL) had inducible ischemia, compared with 45% (79/177) in the lower 4 categories combined (adjusted odds ratio 4.2; 95% confidence interval 1.6 to 11; P=0.004). However, this association differed in users and nonusers of ß-blockers and statins. Among 89 participants who did not use ß-blockers, 93% in the highest CRP category had exercise-induced ischemia, compared with 42% in the lower 4 categories (P=0.03). Among 67 participants who did not use statins, 94% in the highest CRP category had exercise-induced ischemia, compared with 44% in the lower 4 categories (P=0.009). We did not observe a significant association between CRP and ischemia among participants who were treated with either of these medications.

Conclusion— Elevated CRP levels are associated with inducible ischemia in patients with stable coronary disease, particularly among those not treated with ß-blockers or statins.

Key Words: coronary disease • ischemia • risk factors • inflammation • epidemiology

This article has been cited by other articles:

				C. M. Caska, B. E. Hendrickson, M. H. Wong, S. Ali, T. Neylan, and M. A. Whooley Anger Expression and Sleep Quality in Patients With Coronary Heart Disease: Findings From the Heart and Soul Study Psychosom Med, April 1, 2009; 71(3): 280 - 285. [Abstract] [Full Text] [PDF]

				E. S. Williams, S. J. Shah, S. Ali, B. Y. Na, N. B. Schiller, and M. A. Whooley C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study Eur J Heart Fail, January 1, 2008; 10(1): 63 - 69. [Abstract] [Full Text] [PDF]

				J. H. Ix, M. G. Shlipak, G. M. Chertow, and M. A. Whooley Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study Circulation, January 16, 2007; 115(2): 173 - 179. [Abstract] [Full Text] [PDF]

				J. H. Ix, G. M. Chertow, M. G. Shlipak, V. M. Brandenburg, M. Ketteler, and M. A. Whooley Fetuin-A and kidney function in persons with coronary artery disease--data from the heart and soul study Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2144 - 2151. [Abstract] [Full Text] [PDF]

				A. R. Lucas, R. Korol, and C. J. Pepine Inflammation in Atherosclerosis: Some Thoughts About Acute Coronary Syndromes Circulation, May 2, 2006; 113(17): e728 - e732. [Full Text] [PDF]

				J. H. Ix, M. G. Shlipak, V. M. Brandenburg, S. Ali, M. Ketteler, and M. A. Whooley Association Between Human Fetuin-A and the Metabolic Syndrome: Data From the Heart and Soul Study Circulation, April 11, 2006; 113(14): 1760 - 1767. [Abstract] [Full Text] [PDF]

				H.T. Ong The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient QJM, August 1, 2005; 98(8): 599 - 614. [Abstract] [Full Text] [PDF]

				S. Steiner, W. S. Speidl, J. Pleiner, D. Seidinger, G. Zorn, C. Kaun, J. Wojta, K. Huber, E. Minar, M. Wolzt, et al. Simvastatin Blunts Endotoxin-Induced Tissue Factor In Vivo Circulation, April 12, 2005; 111(14): 1841 - 1846. [Abstract] [Full Text] [PDF]

				D. M. Roden An Underrecognized Challenge in Evaluating Postmarketing Drug Safety Circulation, January 25, 2005; 111(3): 246 - 248. [Full Text] [PDF]

				Y. Mitani, H. Sawada, H. Hayakawa, K. Aoki, H. Ohashi, M. Matsumura, K. Kuroe, H. Shimpo, M. Nakano, and Y. Komada Elevated Levels of High-Sensitivity C-Reactive Protein and Serum Amyloid-A Late After Kawasaki Disease: Association Between Inflammation and Late Coronary Sequelae in Kawasaki Disease Circulation, January 4, 2005; 111(1): 38 - 43. [Abstract] [Full Text] [PDF]

				M. C. Odden, M. A. Whooley, and M. G. Shlipak Association of Chronic Kidney Disease and Anemia with Physical Capacity: The Heart and Soul Study J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2908 - 2915. [Abstract] [Full Text] [PDF]

				S. P. Zhao, L. Liu, Y. C. Cheng, M. H. Shishehbor, M. H. Liu, D. Q. Peng, and Y. L. Li Xuezhikang, an Extract of Cholestin, Protects Endothelial Function Through Antiinflammatory and Lipid-Lowering Mechanisms in Patients With Coronary Heart Disease Circulation, August 24, 2004; 110(8): 915 - 920. [Abstract] [Full Text] [PDF]

				M. Schillinger, M. Exner, W. Mlekusch, J. Amighi, S. Sabeti, M. Muellner, H. Rumpold, O. Wagner, and E. Minar Statin therapy improves cardiovascular outcome of patients with peripheral artery disease Eur. Heart J., May 1, 2004; 25(9): 742 - 748. [Abstract] [Full Text] [PDF]

				C. Zoccali, F. Mallamaci, and G. Tripepi Novel Cardiovascular Risk Factors in End-Stage Renal Disease J. Am. Soc. Nephrol., January 1, 2004; 15(90010): S77 - 80. [Abstract] [Full Text]

				J. H. Ix, M. G. Shlipak, H. H. Liu, N. B. Schiller, and M. A. Whooley Association between Renal Insufficiency and Inducible Ischemia in Patients with Coronary Artery Disease: The Heart and Soul Study J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3233 - 3238. [Abstract] [Full Text] [PDF]

				CRP Predicts Inducible Ischemia in Stable Coronary Disease Journal Watch (General), February 25, 2003; 2003(225): 1 - 1. [Full Text]